The Physiologically Difficult Airway
RCEM CPD in London this week and I am off to give a talk on this interesting and ever developing topic. Hope to see some of you there. Although I […]
The Physiologically Difficult Airway Read More »
RCEM CPD in London this week and I am off to give a talk on this interesting and ever developing topic. Hope to see some of you there. Although I […]
The Physiologically Difficult Airway Read More »
Semi-structured interviews are a great way to get the really rich data we need to understand something in greater depth. They allow us to ask ‘why?’ as well as just ‘what?’, ‘who?’ and ‘when?’.
Semi Structured Interviews (CAN9) Read More »
St Emlyn’s Journal Club on the future of EBM with a twist. Really interesting article in Nature Medicine this month with implications for EM research. #FOAMed @stemlyns @VivekSubbiah
JC: The future of evidence based medicine. St Emlyn’s. Read More »
I’ve been reflecting on why there is disagreement about how influential new evidence is to clinical practice in the last year or so. COVID-19 has shown that the thresholds for
Bayes and Belief: How pre-review belief influences critical appraisal. St Emlyn’s Read More »
Our regular round up of the best of the blog and podcast from January 2021 with Iain and Simon. The links to the articles are below together with a link
January 2021 round up podcast: St Emlyn’s Read More »
This week JAMA published three important trials on the use of steroids in patients with severe COVID-19, with an additional cherry on top; a subsequent inclusive meta-analysis (totalling 7 RCTs
The ‘Roid’ to Recovery? REMAP-CAP @ St Emlyn’s Read More »
We have previously covered the RECOVERY trial on St Emlyn’s noting that the first results out of this large pragmatic, adaptive design platform RCT showed no benefit to Hydroxychloroquine. A
Dexamethasone, COVID-19 and the RECOVERY trial. St Emlyn’s Read More »
We’ve talked about the RECOVERY trial on the blog and podcast before. This is a UK based platform trial (more on this later) looking at patients admitted to hospital with
The RECOVERY platform trial: No benefit to Hydroxychloroquine in Covid-19. St Emlyn’s Read More »